Windtree Therapeutics, Inc.
WINT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $4 |
| - Cash | $0 | $0 | $1 | $2 |
| + Debt | $3 | $9 | $2 | $2 |
| Enterprise Value | $3 | $8 | $0 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | $0 | -$11 | -$4 | $3 |
| % Margin | – | – | – | 3,076.7% |
| Net Income | -$29 | -$11 | -$4 | $3 |
| % Margin | – | – | – | 3,074.4% |
| EPS Diluted | -1.08 | -3.06 | -4.63 | 0.27 |
| % Growth | 64.7% | 33.9% | -1,814.8% | – |
| Operating Cash Flow | -$6 | -$3 | -$2 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$3 | -$2 | -$4 |